Compounded Semaglutide: What It Is & What to Know
An evidence-conscious introduction to compounded semaglutide, how it differs from FDA-approved products, and questions to ask before treatment.
Key points
- FDA says compounded drugs are not FDA-approved and do not undergo premarket review for safety, quality or effectiveness.
- FDA has reported dosing errors associated with some compounded injectable semaglutide products.
- A compounded product may be appropriate only in circumstances addressed by a licensed clinician and applicable compounding law.
How to use this guide
Use this article to prepare questions and understand terminology, then rely on your licensed clinician, dispensing pharmacy, FDA-approved labeling where applicable, and current FDA guidance for medication-specific decisions.
What to verify before making a decision
Confirm the exact product, FDA approval status, prescriber, dispensing pharmacy, total amount billed today, renewal terms, cancellation rules and available clinical follow-up. Program terms can change, so merchant-specific claims should be checked at the source.
Related guides
Sources & update standard
Merchant-specific claims are based on HealthRX’s currently published materials. Regulatory distinctions are checked against FDA materials. We date-stamp substantive reviews because pricing, supply conditions and compounding policy can change.